← FDA DRUG APPROVALS

FDA BLA · BLA761062

EVENITY

Sponsor: AMGEN INC

APPLICATION
BLA761062
TYPE
BLA
ORIGINAL APPROVAL
2019-04-09
LATEST ACTION
2019-12-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

EVENITYPrescription
ROMOSOZUMAB-AQQG 105MG/1.17ML · INJECTABLE · INJECTION

Approval history

2019-12-20Labeling · Supplement 2 · standard — Label ↗AP
2019-04-09Type 1 - New Molecular Entity · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →